In the NAFLD animal model, hepatic GLP-1R expression levels at the NAFL (8 weeks) and NASH (16 weeks) stages were downregulated, consistent with the data in humans
What researchers are now wondering is: could these same signals be used to dial down cravings for drugs or alcohol
Medicaid costs roughly quadrupled between the start of fiscal year 2024 and the end of fiscal year 2025 in per-member monthly payments to Medicaid managed care plans, according to the states Executive Office of Health and Human Services, which administers Rhode Islands Medicaid program
Looking beyond GLP-1 and insulin as payloads (a molecule that increasingly appears to be a poor commercial candidate), 29 at least ten companies are working on device-based solutions to administer proteins and monoclonal antibodies orally and some technologies including the RaniPill have reached Phase I
But the short-term fallout isnt looking good for either former partner
It is about: who challenges what in paragraph IV or biosimilar-related challenges, where the dispute is litigated (US District Courts for ANDA/biosimilar actions), whether a settlement triggers a launch date (carve-outs can delay or narrow market entry), and how courts interpret claim scope for composition vs method claims